2min chapter

5 Live Science Podcast cover image

Tackling Depression

5 Live Science Podcast

CHAPTER

Dernanimab: A Turning Point in the Battle Against Alzheimer's Disease

Drug called Dernanimab has been hailed as a turning point in the fight against Alzheimer's disease. Scientists say that the drug which slowed the cognitive decline by 35% on average allowed people with Alzheimer's disease to keep their independence for longer. It targets the build-up in the brain of the chemical beta amyloid, which is thought to poison nerve cells and can cause Cognitive Decline.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode